Skip to main content
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
Easy-to-follow guides
Independent reviews
Vetted providers
Free to read

Home / Peptide legality / By country / Spain

Peptide legality · Spain · updated 2026-09-22

Are peptides legal in Spain?

Restricted

Peptides are legal in Spain only as authorised prescription medicines (such as the GLP-1 drug semaglutide, sold as Ozempic® and Wegovy®), while unapproved 'research' peptides like BPC-157 and TB-500 hold no Spanish or EU marketing authorisation and cannot be lawfully sold or supplied for human use.

Legal status overview

Peptides are restricted in Spain: those that are authorised medicines are legal but prescription-only, and unapproved research peptides may not be lawfully marketed for human use. Medicines in Spain are regulated by the Spanish Agency of Medicines and Health Products (AEMPS), the national authority that authorises medicinal products and, alongside the EU-wide European Medicines Agency (EMA), controls which peptide drugs may be sold. Approved peptide drugs such as semaglutide require a doctor's prescription, whereas experimental peptides sold as 'research chemicals' fall outside any marketing authorisation and are targeted by AEMPS action against illegal and counterfeit health products.

Key points

  • In Spain the Spanish Agency of Medicines and Health Products (AEMPS) is the highest national authority governing the safety and authorisation of medicines, so any peptide sold as a medicine must be authorised through it. [1]
  • AEMPS both authorises medicines for human use and actively combats illegal drugs and counterfeit health products in Spain, which is the framework under which unapproved 'research' peptides sold online fall. [2]
  • Semaglutide is a legal, authorised medicine in Spain but is available only with a valid prescription from a healthcare professional, whether as Ozempic® (type 2 diabetes) or Wegovy® (obesity). [3]
  • AEMPS announced that the anti-obesity peptide drug Wegovy® (semaglutide) would be sold in Spain by doctor's prescription, confirming GLP-1 weight-loss peptides are prescription-only rather than freely available. [4]
  • BPC-157 is an unapproved, experimental peptide that does not appear in any government health authority's approved-drugs database, meaning it has no marketing authorisation permitting its sale for human use in Spain or the wider EU. [5]
  • BPC-157 was added to the World Anti-Doping Agency (WADA) Prohibited List in 2022 under the S0 Non-Approved Substances category, which covers experimental peptides and research chemicals with no regulatory approval and applies to athletes competing under WADA rules in Spain. [6]
  • For personal import and travel, semaglutide is treated in Spain as a prescription-only medicine that is not a narcotic or psychotropic and needs no controlled-substance permit, but a Spanish pharmacy generally cannot dispense it on a foreign prescription and it should be carried in its original labelled packaging. [7]
  • AEMPS actively monitors and investigates weight-loss peptide drugs, having opened a review of Ozempic® and Saxenda® side effects and issued a directive prioritising Ozempic® for diabetes patients during shortages, showing active regulatory oversight rather than a hands-off approach. [8]

Compound-by-compound status

BPC-157BPC-157 is not an authorised medicine in Spain or the EU and exists only as an unapproved experimental 'research' peptide, so it cannot be lawfully sold or supplied for human use and is banned for athletes under WADA's S0 category. [5]
Semaglutide (GLP-1, e.g. Ozempic®/Wegovy®)Semaglutide is legal and authorised in Spain but strictly prescription-only, sold as Ozempic® for type 2 diabetes and Wegovy® for obesity, and cannot be obtained without a valid prescription. [3]
TB-500 (thymosin beta-4)TB-500 is not an authorised medicine in Spain and is sold only as an unapproved research peptide; no Spain-specific source was retrieved confirming its status, but it falls within the same unapproved-peptide category as BPC-157 and is not lawful to market for human use. (no source found)
Human growth hormone (HGH/somatropin)Somatropin (HGH) is an authorised prescription-only medicine in Spain used for defined endocrine indications; no Spain-specific source was retrieved in this research to cite directly, so this point reflects its general EU regulatory status rather than a confirmed Spanish source. (no source found)

Frequently asked questions

Can I buy peptides in Spain without a prescription?

No. In Spain authorised peptide medicines such as semaglutide are prescription-only and can only be obtained with a valid prescription, while unapproved research peptides like BPC-157 have no marketing authorisation and cannot be legally sold for human use at all. [3]

Can I bring peptides like semaglutide into Spain for personal use?

Semaglutide can be brought into Spain for personal use as it is a prescription-only medicine that is not classed as a narcotic or psychotropic and needs no controlled-substance permit, but it should be kept in its original labelled packaging, and a Spanish pharmacy generally cannot dispense it on a non-Spanish prescription. [7]

Is BPC-157 legal in Spain?

BPC-157 is not legal to sell for human use in Spain because it is an unapproved experimental peptide with no marketing authorisation in Spain or the EU, and it is additionally banned for athletes under WADA's S0 Non-Approved Substances category. [5]

Who regulates peptides and weight-loss drugs in Spain?

Peptides and weight-loss drugs in Spain are regulated by the Spanish Agency of Medicines and Health Products (AEMPS), the country's highest authority on medicine safety, working alongside the EU's European Medicines Agency (EMA). [1]

Does Spain take action against illegal peptides sold online?

Yes. AEMPS is tasked with fighting illegal drugs and counterfeit health products in Spain, and it actively monitors weight-loss drugs, having investigated side effects of Ozempic® and Saxenda® and issued directives on their use. [2]

Sources

  1. Spanish Agency of Medicines and Medical Devices, Wikipedia (retrieved 2026-09-22)
  2. Spain: Medicine and Health Products Agency (AEMPS), globalEDGE, Michigan State University (retrieved 2026-09-22)
  3. The anti-obesity drug Wegovy® goes on sale in Spain, Risaku (retrieved 2026-09-22)
  4. Anti-obesity drug Wegovy® to be sold in Spain starting from tomorrow, Science Media Centre España (retrieved 2026-09-22)
  5. BPC-157: A Prohibited Peptide and an Unapproved Drug Found in Health and Wellness Products, Operation Supplement Safety (OPSS) (retrieved 2026-09-22)
  6. Athlete Advisory: Explanation of Key Changes on 2022 WADA Prohibited List, U.S. Anti-Doping Agency (retrieved 2026-09-22)
  7. Semaglutide in Spain: Import Rules & Brands, Nomedic (retrieved 2026-09-22)
  8. Spain investigates side-effects of weight-loss drugs Ozempic® and Saxenda®, Olive Press News Spain (retrieved 2026-09-22)

Last researched: 2026-09-22.

General information based on the sourced research above, not legal advice. Laws change and enforcement varies; for a specific situation in Spain, consult a licensed attorney or the national regulator.